Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-138541

Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2016-08-22 Option exercise +13,100 $2.01 $26,331 128,789 D
Myszkowski Kenneth Allen Chief Financial Officer 2016-08-22 Sale −13,100 $8.00 $104,800 115,689 D
Myszkowski Kenneth Allen Chief Financial Officer 2016-08-23 Option exercise +6,900 $2.01 $13,869 122,589 D
Myszkowski Kenneth Allen Chief Financial Officer 2016-08-23 Sale −6,900 $8.00 $55,200 115,689 D
Derivatives
Myszkowski Kenneth Allen Chief Financial Officer 2016-08-22 Option exercise · Stock Option (right to buy) −13,100 348,900 D
Myszkowski Kenneth Allen Chief Financial Officer 2016-08-23 Option exercise · Stock Option (right to buy) −6,900 342,000 D
Open-market sales · 20,000 sh · avg $8.00 · $160,000
Loading xslF345X03/doc4.xml…